Dynamic Visualization II addresses the challenge of clearly observing and adapting processing parameters for changes in contrast and density due to dense anatomy, structural obstructions, orthopedic hardware, differences in thicknesses and over and under penetrated areas. Dynamic Visualization II takes full advantage of the wide range of image data acquired with the high sensitivity of Fujifilm's advanced detector technologies. Dynamic Visualization II Image Processing provides improved contrast and density stability throughout the entire exposure region and achieves improved anatomic structure visibility across a wider range of patient thicknesses, especially for bariatric imaging.
To register for a product demonstration at RSNA 2016 or to learn more about Fujifilm's comprehensive digital x-ray portfolio, please visit: http://rsna.fujimed.com/
* Dynamic Visualization II will be made commercially available in the US upon receipt of FDA Clearance
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fujifilm-showcases-latest-dynamic-visualization-ii--image-processing-at-rsna-2016-300367794.html
SOURCE FUJIFILM Medical Systems U.S.A., Inc.